Showing all 30 results
Azilsartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the Medoxomil ester.
Active Ingredient Strength Primary Clinical Function Azilsartan Medoxomil Potassium 40 mg The Standard Initiation Unit: The primary starting dose for most adult patients with hypertension. Azilsartan Medoxomil Potassium 80 mg The High-Potency Payload: For patients requiring additional blood pressure lowering beyond the 40 mg dose. Excipients Proprietary Matrix Hydrolysis-Stable System: Engineered to prevent premature breakdown of the prodrug before it reaches the gastrointestinal tract. CILNIDIPINE & TELMISARTAN TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed exclusively in secure, high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Telmisartan and light-sensitive Cilnidipine.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg The Hormonal Stabilizer: Blocks the RAAS system to provide 24-hour systemic pressure control and metabolic benefits (PPAR-gamma activation). Cilnidipine USP/Ph.Eur. 10 mg The Vascular Relaxant: Provides immediate N-type and L-type calcium channel blockade to lower peripheral resistance without edema. Excipients Meglumine / Sorbitol / Sodium Hydroxide / Magnesium Stearate / Titanium Dioxide (Opaque Coating) Solubilizer / Diluent / PH Modifier / Light Shield (Engineered specifically utilizing Alkaline Matrix Solubilization. Telmisartan requires a highly alkaline environment to dissolve, while Cilnidipine is light-sensitive. Our bilayer technology ensures each API is released at its peak kinetic window). Clindipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Cardiovascular Tablet, packed exclusively in highly secure, opaque Alu-Alu blister strips to ensure the absolute chemical stability of the highly photosensitive active ingredient.
Active Ingredient Strength Primary Clinical Function Cilnidipine USP/Ph.Eur. 5 mg The Geriatric & Titration Anchor: The definitive starting dose utilized for elderly patients or those with mild essential hypertension to prevent sudden hypotensive episodes. Cilnidipine USP/Ph.Eur. 10 mg The Global Maintenance Standard: The standardized daily therapeutic payload utilized for the vast majority of adult patients requiring chronic 24-hour blood pressure control. Cilnidipine USP/Ph.Eur. 20 mg The Severe Refractory Macrodose: Utilized strictly for severe, uncontrolled hypertension where the 10mg dose has failed to achieve target blood pressure metrics. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Densifier / Superdisintegrant / Binder / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Cilnidipine is intensely sensitive to UV and visible light; this opaque coating guarantees 100% of the active molecule survives to reach the patient’s systemic circulation) *Pack Sizes: 10×10 Opaque Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Metoprolol & Amlodipin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined molecules.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Tartrate/Succinate ER) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac workload, and neutralizes CCB-induced reflex tachycardia. Amlodipine (as Besylate) Ph.Eur./USP 5 mg Calcium Channel Blocker (CCB): Forces profound peripheral arterial vasodilation, dropping severe blood pressure and relieving coronary spasms. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Crospovidone / Magnesium Stearate / Premium Opadry Film / Iron Oxide Colors Diluent / Stabilizing Buffer / Superdisintegrant / Lubricant (Engineered specifically using bilayer press technology to physically separate the slightly acidic Metoprolol salt from the basic Amlodipine, preventing destructive chemical cross-talk) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
METOPROLOL + RAMIPRIL TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Succinate/Tartrate) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death. Ramipril Ph.Eur./USP 2.5 mg / 5 mg ACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling. Excipients Microcrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide Colors Low-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
Nebivolol & Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic and pH-sensitive active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Nitric Oxide Donating Beta-Blocker: Reduces cardiac workload while promoting active peripheral vasodilation and preserving sexual function. Telmisartan Ph.Eur./USP 40 mg Metabolic ARB: Provides sustained 24-hour RAAS blockade and improves cellular insulin sensitivity (PPAR-γ modulation). Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Povidone K30 / Polysorbate 80 / Magnesium Stearate Alkalizing Agents (Meglumine) / Diluent / Binder / Surfactant (Engineered specifically to create a hyper-alkaline micro-environment for Telmisartan dissolution, physically isolated from the Nebivolol layer to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 5 mg Cardioselective & Vasodilatory Base: Reduces cardiac workload and provides active Nitric Oxide-driven peripheral vasodilation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Thiazide Diuretic Driver: Forces the excretion of excess sodium and water, massively amplifying the blood-pressure-lowering effect of the beta-blocker. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Polysorbate 80 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Wetting Surfactant / Moisture-Barrier Coating (Engineered specifically to protect the highly delicate racemic Nebivolol balance while ensuring rapid, synchronized gastric dissolution of the diuretic) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Nicotinic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymer.
Active Ingredient Strength Primary Clinical Function Nicotinic Acid (Niacin) USP/Ph.Eur. 500 mg (ER) Initiation / Titration Standard: Base therapeutic unit for the mandatory, slow 4-week dose titration protocol required to build patient tolerance. Nicotinic Acid (Niacin) USP/Ph.Eur. 1000 mg (ER) Global Cardiology Standard: High-dose adult maintenance therapy for severe mixed dyslipidemia and extreme hypertriglyceridemia. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Stearic Acid / Colloidal Silicon Dioxide / Premium Opadry Film Hydrophilic Polymer Matrix / Diluent / Lubricant / Glidant (Engineered specifically to form a viscous, highly controlled gel barrier upon swallowing, metering the API release precisely into the gastrointestinal tract over 8-12 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic cardiology dispensing regimens).
Olmesartan + Amlodipine + Hydroclorthiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients across their entire shelf life.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg / 40 mg ARB Base: Blocks the renin-angiotensin-aldosterone system (RAAS) and provides critical diabetic renoprotection. Amlodipine (as Besylate) Ph.Eur./USP 5 mg / 10 mg CCB Vasodilator: Forces profound, sustained peripheral arterial relaxation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Diuretic Volume Controller: Flushes excess sodium/water and massively amplifies the efficacy of the ARB component. Excipients Silicified Microcrystalline Cellulose / Pregelatinized Starch / Croscarmellose Sodium / Magnesium Stearate / Opadry Protective Film Moisture-Scavenging Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to physically isolate the highly sensitive Olmesartan ester from the alkaline Amlodipine salt to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Perindopril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.
Active Ingredient Strength Primary Clinical Function Perindopril Erbumine Ph.Eur./USP 2 mg Initiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension. Perindopril Erbumine Ph.Eur./USP 4 mg Hypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension. Perindopril Erbumine Ph.Eur./USP 8 mg Cardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium Stearate Diluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Prasugrel Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips containing dedicated desiccants to ensure the absolute chemical stability of the highly volatile thienopyridine molecule.
Active Ingredient Strength Primary Clinical Function Prasugrel HCl INN/Ph.Eur. 5 mg Dose-Adjusted Standard: Maintenance dose strictly for vulnerable patients weighing < 60 kg or aged ≥ 75 years to minimize fatal bleeding risk. Prasugrel HCl INN/Ph.Eur. 10 mg Global Clinical Standard: Standard adult maintenance dose following a 60 mg acute loading dose in the Cath Lab. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Hypromellose / Triacetin Diluent / Superdisintegrant / Moisture-Barrier Film-Coating (Engineered specifically to prevent hydrolytic degradation and ensure ultra-fast gastric release) *Pack Sizes: 10×10 Alu-Alu Blisters or 28/30-Tablet Calendar Blisters (Optimized specifically for strict 12-month post-PCI dual-antiplatelet dispensing regimens).
RAMIPRIL & HYDROCLORTHIAZIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Rivaroxaban Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the potent DOAC molecule.
Active Ingredient Strength Primary Clinical Function Rivaroxaban INN/Ph.Eur. 2.5 mg Vascular Dose: Co-administered with Aspirin to prevent major cardiovascular events in CAD/PAD. Rivaroxaban INN/Ph.Eur. 10 mg Surgical Prophylaxis: Prevention of DVT following knee or hip replacement surgery. Rivaroxaban INN/Ph.Eur. 15 mg / 20 mg Global Clinical Standard: Treatment of acute DVT/PE and stroke prevention in Atrial Fibrillation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Sodium Lauryl Sulfate / Magnesium Stearate Diluent / Superdisintegrant / Surfactant (Engineered for optimal solubilization and synchronized gastrointestinal absorption) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28/30-Tablet Blisters (Optimized specifically for strict chronic cardiology and acute post-op dispensing regimens).
Rosuvastatin + Fenofibrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer or Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive Rosuvastatin calcium salt.
Active Ingredient Strength Primary Clinical Function Rosuvastatin Calcium INN/Ph.Eur. 10 mg or 20 mg (Equivalent to Rosuvastatin base) Potent HMG-CoA Reductase inhibition for massive LDL reduction and plaque stabilization. Fenofibrate (Micronized) INN/Ph.Eur. 160 mg (or 145 mg Nanoparticle) Global Clinical Standard: PPAR-alpha agonism for severe hypertriglyceridemia and HDL elevation. Excipients Lactose Monohydrate / Sodium Lauryl Sulfate / Crospovidone / Magnesium Stearate Diluent / Surfactant / Superdisintegrant (Engineered with heavy surfactant loading to force the insoluble Fenofibrate into systemic circulation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic cardiology dispensing regimens).
Sacubutril + Valsartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive dual-molecule complex.
Active Ingredient Strength (Total Dose) Primary Clinical Function Sacubitril / Valsartan INN/Ph.Eur. 24 mg / 26 mg (50 mg Total) Starting dose for patients with severe renal impairment, hepatic impairment, or those not currently taking an ACEi/ARB. Sacubitril / Valsartan INN/Ph.Eur. 49 mg / 51 mg (100 mg Total) Standard Initiation Dose: For patients switching from standard doses of ACE inhibitors or ARBs. Sacubitril / Valsartan INN/Ph.Eur. 97 mg / 103 mg (200 mg Total) Target Maintenance Dose: Maximum adult therapy for optimal mortality reduction in heart failure. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 14×2 or 28-Tablet Alu-Alu Blisters (Optimized specifically for strict twice-daily chronic cardiology dispensing regimens).
Telmisartan 40Mg + Amlodipine 5Mg + Hydroclorthiazide 12.5Mg Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Multi-Layer or Segregated Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic ARB and the sensitive CCB.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Continuous 24-hour peripheral vasodilation and potassium-sparing RAAS blockade. Amlodipine Besylate USP/Ph.Eur. 5 mg (Equivalent to Amlodipine base) Calcium channel blockade for direct arterial relaxation and anti-anginal defense. Hydrochlorothiazide (HCTZ) USP/Ph.Eur. 12.5 mg Thiazide diuresis for blood volume reduction and mitigation of peripheral edema. Excipients Meglumine / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate Alkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation) *Pack Sizes: 10×10 or 10×15 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology adherence regimens).
Telmisartan 40Mg + Chlorthalidone 6.25Mg Tablet
FreeA Telmisartan 40mg + Chlorthalidone 6.25mg tablet is a fixed-dose combination antihypertensive medication used to treat high blood pressure (hypertension) when a single medicine is not effective enough.
Telmisartan 40mg and Atorvastatin 10mg Tablet
FreeA Telmisartan 40mg + Atorvastatin 10mg tablet is a combination medication used to treat patients suffering from both high blood pressure (hypertension) and high cholesterol (hyperlipidemia).
Telmisartan 40mg and Metoprolol 25mg Tablets
FreeA Telmisartan 40mg + Metoprolol 25mg tablet is a combination antihypertensive medication used to manage high blood pressure (hypertension).
Telmisartan 50Mg + Metoprolol Succinate Entric Coated 40Mg Tablets
FreeA Telmisartan 40mg + Metoprolol Succinate 50mg (often referred to as enteric-coated or extended-release) tablet is a fixed-dose combination antihypertensive medication. It is primarily used to treat hypertension (high blood pressure) when a single medicine is insufficient, as well as to reduce the risk of heart attack and stroke.
Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.
Active Ingredient Strength Primary Clinical Use Telmisartan USP/BP/Ph.Eur. 20 mg Initiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients. Telmisartan USP/BP/Ph.Eur. 40 mg Standard Global Dose: Once-daily maintenance therapy for essential hypertension. Telmisartan USP/BP/Ph.Eur. 80 mg Maximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction. Excipients Meglumine / Sodium Hydroxide / Povidone / Magnesium Stearate Alkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption) Ticagrelor Tablets
FreeTicagrelor tablets primarily contain Ticagrelor as the active pharmaceutical ingredient. It is a direct-acting P2Y12 receptor antagonist used as an antiplatelet medication to prevent blood clots in patients with a history of heart attack or acute coronary syndrome (ACS)
Torsemide Tablet
FreeTorsemide tablets (also spelled Torasemide) primarily contain Torsemide as the active pharmaceutical ingredient. It is a potent loop diuretic, often referred to as a “water pill,” used to treat high blood pressure and fluid retention (edema) caused by heart, kidney, or liver disease.
Trimetazidine Tablet
FreeTrimetazidine tablets primarily contain Trimetazidine Hydrochloride (or Dihydrochloride) as the active ingredient. It is an anti-anginal metabolic agent that improves heart efficiency by shifting its energy source from fatty acids to glucose
